Bosulif

Indicated For

Chronic myeloid leukemia (CML)

About This Medication

# Pfizer Patient Assistance Program Patient Guide: How to Get Bosulif (bosutinib) at Low or No Cost Bosulif (bosutinib) is a targeted therapy medication used to treat adults with chronic myeloid leukemia (CML), a type of blood cancer where the bone marrow produces too many abnormal white blood cells. This guide explains how the **Pfizer Patient Assistance Program** can provide **Bosulif at no cost** if you meet eligibility criteria, primarily for uninsured patients or those with government insurance facing financial hardship.[1][3][5] ## About Bosulif (bosutinib) **Bosulif** is a prescription tablet taken once daily to help control CML by blocking specific proteins that cause cancer cells to grow. It's approved for newly diagnosed chronic phase Philadelphia chromosome-positive (Ph+) CML and for patients resistant or intolerant to prior therapies. Common side effects include diarrhea, nausea, rash, and low blood counts—always discuss with your doctor. Treatment is lifelong for many patients, making affordability crucial.[3][7] The Pfizer Patient Assistance Program (PAP), jointly run by Pfizer Inc. and the Pfizer Patient Assistance Foundation, offers free medications like Bosulif to eligible U.S. patients (including Puerto Rico and U.S. Virgin Islands). It's designed for those without adequate prescription coverage who can't afford their medicine.[1][4][5] ## Who Qualifies? Eligibility focuses on financial need, residency, and insurance status: - **U.S. residency**: Must live in the U.S., Puerto Rico, or U.S. Virgin Islands.[4] - **Prescription**: Valid prescription from a U.S.-licensed healthcare provider for outpatient use.[5] - **Insurance**: Uninsured or government-insured (e.g., Medicare, Medicaid) with insufficient coverage. **Commercially insured patients do not qualify**—use the separate Bosulif Copay Program or Pfizer Oncology Together instead.[2][5] - **Income**: Typically up to **400-500% of the Federal Poverty Level (FPL)** for uninsured patients. Exact thresholds vary; programs assess household income.[1][2] **Income Eligibility Breakdown** Use this table to estimate eligibility based on 2026 FPL guidelines (approximate; check current FPL at ASPE.hhs.gov). Income includes all household earnings. | Household Size | 400% FPL (Annual Income) | 500% FPL (Annual Income) | Notes | |---------------|---------------------------|---------------------------|-------| | 1 person | $60,240 | $75,300 | Individual threshold not fixed; assessed case-by-case[1] | | 2 people | $81,760 | $102,200 | Couple threshold varies[1] | | 3 people | $103,280 | $129,100 | Family of 3[1][2] | | 4 people | $124,800 | $156,000 | Family of 4; add ~$21,520 per person at 400%[1][2] | | 5+ people | Varies | Varies | Contact program for exact[2] | *Notes*: Thresholds are guidelines—Pfizer reviews total financial picture. Higher limits (up to 500% FPL) may apply via foundations for Medicare patients.[2] ## Insurance Requirements - **Uninsured**: Primary candidates; free Bosulif if income-qualified.[3] - **Medicare/Medicaid**: Eligible if coverage doesn't fully pay and income meets limits. May need to apply for Extra Help (Low-Income Subsidy) first or provide denial proof.[2][3][5] - **Commercial/Private Insurance**: **Not eligible** for PAP. Instead: - **Bosulif Copay Card**: Reduces copays to $0 for many (commercial plans only).[2][7] - **Pfizer Oncology Together**: Free 30-day trial voucher for new patients; call 1-877-744-5675.[7] - Foundation grants for copays (income up to 500% FPL).[2] Patients with any insurance must exhaust other options (e.g., Extra Help, Medicaid) and provide denial letters before PAP consideration.[5][6] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit **www.PfizerRxPathways.com** Program Finder, enter "Bosulif," and follow prompts. Use Pfizer PAP Connect for online apps if available.[1][5] 2. **Gather Documents**: - Proof of income (W-2, tax return, pay stubs). - Proof of residency (utility bill, lease). - Valid prescription. - Insurance details/denials.[1][4][5] 3. **Complete Form**: Patient and doctor sections required. Download printable forms or apply online/manual. Doctor signs.[1][4] 4. **Submit**: Online via PAP Connect, mail, or fax (866-470-1748). Pfizer Oncology Together (1-877-744-5675) can guide.[3][4][7] 5. **Wait for Approval**: 2-4 weeks; you'll get status notification.[1][2] **Pro Tip**: Call Pfizer RxPathways or a specialty pharmacy like QuickRx (800-496-6111) for free help—they handle paperwork.[2] ## Timeline and Delivery - **Processing**: 2-3 weeks typically; up to 4 weeks. Rush for urgent needs possible.[1][2] - **Notification**: Mailed/email confirming enrollment. - **Supply**: Varies (often 1-12 months); **reauthorization required** annually or as supply ends.[3][4] - **Delivery**: Shipped free to your home or doctor's office.[1] ## Alternatives if Denied - **Appeal**: Provide more docs or updated income. - **Copay Programs**: Commercial insurance? Bosulif Copay Card ($0 copay).[2] - **Foundations**: PAN Foundation, HealthWell (up to 500% FPL for Medicare).[2] - **Pfizer Oncology Together**: Trial voucher, reimbursement help (1-877-744-5675).[7] - **State Programs**: Medicaid expansion or local aid. - **Generic**: No biosimilars yet; check for future bosutinib generics.[2] - **QuickRx Specialty**: Free enrollment support (917-830-2525).[2] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, processes, and FPL change—**always verify at PfizerRxPathways.com or call 1-844-989-7284**. Not medical/financial advice; consult your doctor and advisor. Pfizer may require other aid applications first. Program can end or modify without notice.[1][5]

Program information last verified: March 25, 2026